Interferon alpha-2b biosimilar (Pharmaclon)

干扰素α-2b生物类似药 (Pharmaclon)

Report date: 2024/05/29 10:50:42

Base Information

Drug NameInterferon alpha-2b biosimilar (Pharmaclon)
Drug Alias NameInterferon alfa-2b biosimilar (Pharmaclon)干扰素α-2b生物仿制药 (Pharmaclon)AlpharonaAlfaronAlfarona
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionImmunostimulantsInnate antiviral immune response inducersInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsRespiratory papillomatosisThrombocytopeniaConjunctivitis +[16] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPharmaclon
China Registration ClassN/A

Develop Information

Active CompaniesPharmaclon
Inactive CompaniesN/A
Active IndicationsRespiratory papillomatosisThrombocytopeniaConjunctivitis +[16] 
Inactive IndicationsN/A

Other Information

ATC CodeL03AB05
Related LinksN/A